Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K/Akt/mTOR Regulated Signaling Pathways in Pancreatic Cancer

CORC > 兰州大学 > 兰州大学 > 第二临床医学院 > 期刊论文

	Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K/Akt/mTOR Regulated Signaling Pathways in Pancreatic Cancer
	Mu, GG; Zhang, LL; Li, HY; Liao, Y; Yu, HG
刊名	DIGESTIVE DISEASES AND SCIENCES
	2015-04
卷号	60 期号:4 页码:1067-1080
关键词	Notch1 PTEN Pancreatic cancer Thymoquinone Chemoresistance Apoptosis
ISSN号	0163-2116
通讯作者	Yu, HG (reprint author), Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430060, Hubei Province, Peoples R China.
学科主题	Gastroenterology & Hepatology
收录类别	SCIE ; PUBMED ; MEDLINE
出版地	DORDRECHT
语种	英语
WOS记录号	WOS:000354464900041
内容类型	期刊论文
源URL	[http://ir.lzu.edu.cn/handle/262010/179351]
专题	第二临床医学院_期刊论文
推荐引用方式 GB/T 7714	Mu, GG,Zhang, LL,Li, HY,et al. Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K/Akt/mTOR Regulated Signaling Pathways in Pancreatic Cancer[J]. DIGESTIVE DISEASES AND SCIENCES,2015,60(4):1067-1080.
APA	Mu, GG,Zhang, LL,Li, HY,Liao, Y,&Yu, HG.(2015).Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K/Akt/mTOR Regulated Signaling Pathways in Pancreatic Cancer.DIGESTIVE DISEASES AND SCIENCES,60(4),1067-1080.
MLA	Mu, GG,et al."Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K/Akt/mTOR Regulated Signaling Pathways in Pancreatic Cancer".DIGESTIVE DISEASES AND SCIENCES 60.4(2015):1067-1080.